Asian Stocks Rise as AI Chip Rally Offsets Middle East Tensions 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Japan Eyes Bigger GPIF Investment in Domestic Assets as BOJ Independence Concerns Grow 
Gold Prices Set for Weekly Loss as Iran Tensions and Fed Rate Outlook Weigh 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
US Stock Futures Steady as Oil Prices Ease, Iran Talks Boost Market Sentiment 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
Gold Price Climbs Over 1% as Dollar Weakens, Fed Rate Debate and Iran Tensions Remain in Focus 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
Bernstein Raises 2026 Nickel Price Forecast as Indonesia Tightens Supply 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Lotte Group will look for new growth engines, and its chairman Shin Dong Bin said they will especially focus on mobility and the healthcare sector for this. The chief said they are making this move as the company is facing an unfavorable business environment following the credit downgrades of its affiliates.
Lotte Group’s chairman shared this plan with the public during the 2023 Second Half Value Creation Meeting (VCM) which he personally hosted at the Lotte World Tower in Seoul on Tuesday, July 18. He organized this event to talk about the company’s management as well as their medium to long-term strategies.
Shin also mentioned the Lotte Group’s goal to find new growth engines with a focus on mobility and health, and wellness. According to The Korea Times, around 80 executives attended the VCM event led by Chairman Shin. The CEO of Lotte Holdings, Lee Dong Woo, was also there, along with heads of different business units, subsidiary representatives, and executives of Lotte Holdings.
With the company’s plans to expand its health and wellness unit, officials have naturally tackled some issues in South Korea, including the aging population and low birth rate, to assess what Lotte can do. They also touched on the subject of digital transformation, changing corporate management environments, and sustainable growth.
As part of the Lotte Group’s move to facilitate new growth engines in the area of health and wellness, its Contract Development Manufacturing Organization (CDMO) unit, Lotte Biologics, will expand its business to be included in the world’s top 10 by 2030.
To do this, it will build three mega plants in the country within seven years with a target total production capacity of 360,000 liters of antibody drugs. Lotte will also set up small-scale and finished pharma facilities to produce clinical materials.
“Ignoring the rapidly changing business environment and stubbornly sticking to past successes won’t work any longer,” The Korea Economic Daily quoted Shin Dong Bin as saying. “We must create our own ways of work that align with the current environment through flexible thinking. You cannot survive unless you try something new.”
Photo by: Lotte Newsroom
